1. Home
  2. Upcoming Events
advertisement

Beyond Artificial Tears – Evaluating Nutraceutical Options for Dry Eye Disease

COPE Accredited CE Offered

Synchronous In-Person Program
1.00 available credits
Information
June 26, 2025
07:00 PM - 09:00 PM CT
Hennepin Arts – Studio 900
800 LaSalle Ave, #1030, Minneapolis, Minnesota, United States
ReachMD Healthcare Image
ENROLL
Details
Presenters

  • Overview

    Dry eye disease (DED) management is entering a new era – one that goes beyond artificial tears to include evidence-based nutritional support as a distinct category of care. In this engaging, case-based symposium, Selina R. McGee, OD, FAAO (Chair); Neda Gioia OD, CNS, IFMCP, FOWNS; and Julie Poteet, OD, MS, CNS, FOWNS; will examine the science behind nutraceutical interventions and their role in a personalized, multimodal approach to DED. Attendees will explore diagnostic tools for characterizing disease severity, review relevant clinical data, and gain practical strategies for incorporating oral supplements into routine management. Rethink what’s possible and expand your approach to treating DED.

  • Target Audience

    This certified continuing medical education activity is designed for optometrists.

  • Grantor Statement

    This activity is supported by an unrestricted educational grant from Bausch + Lomb.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Utilize diagnostic tools to accurately characterize subtypes and severity of DED
    • Summarize clinical evidence regarding nutraceutical interventions for DED
    • Integrate evidence-based nutraceutical approaches into personalized DED management plans

  • Accreditation and Credit Designation Statements

    Evolve Medical Education LLC is a COPE-accredited administrator. 

    This activity, COPE Activity Number 130887, is accredited by COPE for continuing education for optometrists. This course is approved for 1.0 hour of CE.

    Course #: 98212-PH
    Activity #: 130887

    COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

  • Faculty

    Selina R. McGee, OD, FAAO (Chair)
    BeSpoke Vision/Adjunct Professor
    NSUOCO
    Edmond, OK

    Neda Gioia, OD, CNS, IFMCP, FOWNS
    Integrative Vision Corp
    Shrewsbury, NJ

    Julie Poteet, OD, MS, CNS, FOWNS
    MyEyeDr
    Atlanta, GA

  • Disclosure of Relevant Financial Relationships

    DISCLOSURE POLICY
    In accordance with the COPE Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.

    The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.

    Selina R. McGee, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Ocuphir. Consultant: Aldeyra, Alcon, Allergan, Avellino, Bausch + Lomb, Bruder, Cynosure, Dompé, EyeEco, Eyevance, Harrow, Horizon, Kala Pharmaceuticals, Lumenis, Novartis, Optovue, Oyster Point, RVL, Science Based Health, Sun Pharmaceuticals, Tarsus, Thea, Topcon, Versant, Vertical, Vital Tears, Vyluma, and Zeiss. Speaker’s Bureau: Bausch + Lomb, Cynosure, Dompé, EyeEco, Eyevance, Harrow, Lumenis, Oyster Point, and Optovue.

    Neda Gioia, OD, CNS, IFMCP, FOWNS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb. Advisory Board: Retinov.

    Julie Poteet, OD, MS, CNS, FOWNS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb.

    The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

Details
Presenters
Recommended

  • Overview

    Dry eye disease (DED) management is entering a new era – one that goes beyond artificial tears to include evidence-based nutritional support as a distinct category of care. In this engaging, case-based symposium, Selina R. McGee, OD, FAAO (Chair); Neda Gioia OD, CNS, IFMCP, FOWNS; and Julie Poteet, OD, MS, CNS, FOWNS; will examine the science behind nutraceutical interventions and their role in a personalized, multimodal approach to DED. Attendees will explore diagnostic tools for characterizing disease severity, review relevant clinical data, and gain practical strategies for incorporating oral supplements into routine management. Rethink what’s possible and expand your approach to treating DED.

  • Target Audience

    This certified continuing medical education activity is designed for optometrists.

  • Grantor Statement

    This activity is supported by an unrestricted educational grant from Bausch + Lomb.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Utilize diagnostic tools to accurately characterize subtypes and severity of DED
    • Summarize clinical evidence regarding nutraceutical interventions for DED
    • Integrate evidence-based nutraceutical approaches into personalized DED management plans

  • Accreditation and Credit Designation Statements

    Evolve Medical Education LLC is a COPE-accredited administrator. 

    This activity, COPE Activity Number 130887, is accredited by COPE for continuing education for optometrists. This course is approved for 1.0 hour of CE.

    Course #: 98212-PH
    Activity #: 130887

    COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

  • Faculty

    Selina R. McGee, OD, FAAO (Chair)
    BeSpoke Vision/Adjunct Professor
    NSUOCO
    Edmond, OK

    Neda Gioia, OD, CNS, IFMCP, FOWNS
    Integrative Vision Corp
    Shrewsbury, NJ

    Julie Poteet, OD, MS, CNS, FOWNS
    MyEyeDr
    Atlanta, GA

  • Disclosure of Relevant Financial Relationships

    DISCLOSURE POLICY
    In accordance with the COPE Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.

    The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.

    Selina R. McGee, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Ocuphir. Consultant: Aldeyra, Alcon, Allergan, Avellino, Bausch + Lomb, Bruder, Cynosure, Dompé, EyeEco, Eyevance, Harrow, Horizon, Kala Pharmaceuticals, Lumenis, Novartis, Optovue, Oyster Point, RVL, Science Based Health, Sun Pharmaceuticals, Tarsus, Thea, Topcon, Versant, Vertical, Vital Tears, Vyluma, and Zeiss. Speaker’s Bureau: Bausch + Lomb, Cynosure, Dompé, EyeEco, Eyevance, Harrow, Lumenis, Oyster Point, and Optovue.

    Neda Gioia, OD, CNS, IFMCP, FOWNS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb. Advisory Board: Retinov.

    Julie Poteet, OD, MS, CNS, FOWNS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb.

    The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

Recommended

Program Chapters

Segment Chapters

Playlist:

Recommended

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
PrevNext